Publications

  1. De Vivo I, Chang C-P, Cleary —L. The hox cooperativity motif of the chimeric oncoprotein E2a-Pbxl is necessary and sufficient for oncogenesis. Mol Cell Bio 1997;1:81-8.
  2. Cui X, De Vivo I, Slany R, Miyamoto A, Firestein R, Cleary —L. Association of SET domain and myotubularin-related proteins modulates growth control. Nat Genet 1998;18:331-7.
  3. De Vivo I, Cui X, Domen J, Cleary ML. Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1. Proc Natl Acad Sci 1998;95:9471-6.
  4. De Vivo I, Gertig DM, Nagase S, Hankinson SE, O’Brien R, Speizer FE, Parsons R, Hunter DJ. Novel germline mutations in the PTEN tumor suppressor gene found in women with multiple cancers. J Med Genet 2000;37:336-41.
  5. Haiman CA, Hankinson SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, Speizer FE, Hunter DJ. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 2000;87:204-10.
  6. Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. A polymorphism in CYP17 and endometrial cancer risk. Cancer Res 2001;61(10):3955-60.
  7. Guillemette C, De Vivo I, Hankinson SE, Haiman CA, Spiegelman D, Housman DE, Hunter DJ. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev 2001;10(6):711-4.
  8. De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ. Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11(5):489-92.
  9. Hernan MA, Checkoway H, O’Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. Monoamine oxidase B intron 13 and catecol-O-methyltransferase codon 158 polymorphisms, cigarette smoking, and the risk of Parkinson’s disease. Neurology 2002;58(9):1381-7.
  10. Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, Christiani DC. Combinations of the variant genotypes of GSTP1, GSTM1 and p53 are associated with an increased lung cancer risk. Cancer Res 2002;62(10):2819-23.
  11. Han J, Hankinson SE, De Vivo I, Colditz GA, Hunter DJ. No association between a stop codon polymorphism in RAD52 and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11(10):1138-9.
  12. De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ. A functional polymorphism in the promoter of the human progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 2002; 99(19):12263-8.
  13. Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. Association between self reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism. Int J Cancer 2003;104:758-63.
  14. Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 2003;77:27-36.
  15. Tranah GJ, Lescault PJ, Hunter DJ, De Vivo I. Multiple displacement amplification prior to single nucleotide polymorphism genotyping in epidemiologic studies. Biotechnol Lett 2003;25:1031-6.
  16. Cramer DW, Hornstein MD, McShane P, Powers RD, Lescault PJ, Vitonis AF, De Vivo I. Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. Am J Obstet Gynecol 2003;189(4):1085-92.
  17. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter DJ. Interaction between a peroxisome proliferator-activated receptor {gamma} gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 2003;12(22):2923-9.
  18. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ. A functional polymorphism in the progestrone receptor gene is associated with an increase in breast cancer risk. Cancer Res 2003;63(17):5236-8.
  19. Miller DP, Neuberg D, De Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 2003;14(5):545-51.
  20. Han J, Hankinson SE, De Vivo I, Spiegelman D, Tamimi R, Mohrenweiser HW, Colditz GA, Hunter DJ. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res 2003;(in press).
  21. Han J, Hankinson SE, Ranu H, De Vivo I, Hunter DJ. Polymorphisms in DNA double strand break repair genes and breast cancer risk in the Nurses’ Health Study. Carcinogenesis 2003;(in press).